As of 2025-05-17, the Fair Value of Centrexion Therapeutics Corp (CNTX) is -1.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.71 USD, the upside of Centrexion Therapeutics Corp is -309.29%.
With the market price of 0.71 USD and our fair value calculation, Centrexion Therapeutics Corp (CNTX) is not a good investment. Investing in CNTX stocks now will result in a potential loss of 309.29%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 6.64 | -10.46 | -14.84 | -23.96 | -26.73 | -13.87 |
| YoY growth | 204.08% | -257.53% | -41.87% | -61.48% | -11.52% | -33.67% |
| Market Cap (mil) | 63.85 |
| P/E | |
| Forward P/E |
| EPS | -0.30 |
| Avg earnings growth rate | -33.67% |
| TTM earnings | -26.73 |